Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Lipocine (LPCN) over the last 12 years, with Q3 2025 value amounting to $321168.0.

  • Lipocine's Other Working Capital Changes rose 1007.46% to $321168.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $620482.0, marking a year-over-year increase of 47274.47%. This contributed to the annual value of $320000.0 for FY2024, which is 19607.16% up from last year.
  • Lipocine's Other Working Capital Changes amounted to $321168.0 in Q3 2025, which was up 1007.46% from -$66166.0 recorded in Q2 2025.
  • Lipocine's 5-year Other Working Capital Changes high stood at $1.3 million for Q3 2021, and its period low was -$774379.0 during Q2 2022.
  • In the last 5 years, Lipocine's Other Working Capital Changes had a median value of -$96803.0 in 2023 and averaged $20360.9.
  • In the last 5 years, Lipocine's Other Working Capital Changes crashed by 89128.39% in 2022 and then soared by 268215.8% in 2024.
  • Lipocine's Other Working Capital Changes (Quarter) stood at -$29176.0 in 2021, then tumbled by 891.28% to -$289217.0 in 2022, then skyrocketed by 106.27% to $18137.0 in 2023, then soared by 2682.16% to $504600.0 in 2024, then plummeted by 36.35% to $321168.0 in 2025.
  • Its Other Working Capital Changes stands at $321168.0 for Q3 2025, versus -$66166.0 for Q2 2025 and -$139120.0 for Q1 2025.